Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets
Background. Metabolic associated fatty liver disease (MAFLD) is a complex disease that results from the accumulation of fat in the liver. MAFLD is directly associated with obesity, insulin resistance, diabetes, and metabolic syndrome. PPARγ ligands, including pioglitazone, are also used in the manag...
Saved in:
Main Authors: | Fatemeh Kazeminasab, Maryam Baharlooie, Kamran Ghaedi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2022/6161694 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?
by: Athina Kladi-Skandali, et al.
Published: (2015-01-01) -
Noncoding RNAs in Health and Disease
by: Davide Barbagallo, et al.
Published: (2018-01-01) -
Noncoding RNAs in sepsis-associated acute liver injury: Roles, mechanisms, and therapeutic applications
by: Jialian Wang, et al.
Published: (2025-02-01) -
Long Noncoding RNAs, Chromatin, and Development
by: Daniel P. Caley, et al.
Published: (2010-01-01) -
PPARγ as a Novel Therapeutic Target in Lung Cancer
by: Aravind T. Reddy, et al.
Published: (2016-01-01)